MedPath

Carbon Dioxide

Carbon Dioxide

Approved
Approval ID

823bea2a-a5cc-4f94-b93d-80a55bf8ff34

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2023

Manufacturers
FDA

Praxair Distribution, Inc.

DUNS: 042845636

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbon Dioxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59579-003
Application NumberNDA205852
Product Classification
M
Marketing Category
C73594
G
Generic Name
Carbon Dioxide
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 19, 2023
FDA Product Classification

INGREDIENTS (1)

CARBON DIOXIDEActive
Quantity: 990 mL in 1 L
Code: 142M471B3J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carbon Dioxide - FDA Drug Approval Details